PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 4058870

Dominant exudative vitreoretinopathy.

C E van Nouhuys
View original source ↗Export metadata ↓

Abstract

Eleven Dutch families with dominant exudative vitreoretinopathy (DEVR) were studied. The findings in 81 affected members of these families are listed. DEVR is probably based on a late developmental disorder of the foetal retinal vascular system. This disease has changed our concepts of the pathogenesis of congenital retinal folds. We could not confirm the presence of platelet aggregation defects in DEVR.

Explore related subjects

Eye DiseasesFemaleFluorescein AngiographyGenes, DominantHumansMalePedigreePolymorphism, GeneticRetinal DiseasesVisual AcuityVitreous BodyCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C E van Nouhuys. 1985. Dominant exudative vitreoretinopathy.. https://doi.org/10.3109/13816818509007853

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Uses and complications of mitomycin C in ophthalmology.

Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis. Its use and application in ophthalmology has been increasing in recent years because of its modulatory effects on wound healing. Current applications include pterygium surgery, glaucoma surgery, corneal refractive surgery, cicatricial eye disease, conjunctival neoplasia and allergic eye disease. Although it has been used successfully in these conditions, it has also been associated with significant complications. This article reviews the current trends and uses of mitomycin C in the eye and its reported complications.

Eye Diseases↗